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Abstract
This case report details a 30 year old woman with hyperlipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), 
Polycystic Ovarian Syndrome (PCOS) and infertility. Her impaired liver function has prevented the use of pharmaceutical 
drugs (statins and metformin). The patient therefore underwent two stages of Chinese herbal medicine treatment: the 
first formula to ameliorate hyperlipidemia and amenorrhea; and the second formula to improve ovarian dysfunction 
as well as glucose and lipid metabolism. Over 8 months of treatment, the patient achieved pregnancy and a natural 
birth without developing gestational diabetes. While the treatment of coexisting metabolic syndrome conditions is often 
complex and difficult, this case report highlights how Chinese herbal medicine may offer a successful treatment option 
for women with multiple metabolic abnormalities and associated infertility.
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Introduction
Polycystic Ovarian Syndrome (PCOS) is the most common 
reproductive endocrine disease with a prevalence of 5-10% in 
women of reproductive age [1]. The clinical features of PCOS are 
heterogeneous and vary in intensity. Hirsutism, oligomenorrhea or 
amenorrhea contributing to chronic anovulation and infertility are the 
most frequent conditions observed [2]. PCOS is also associated with 
several metabolic disturbances which characterize metabolic syndrome 
such as obesity, dyslipidemia and insulin resistance [3]. More recently, 
increased prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) 
has been reported in patients with PCOS [4]. NAFLD entails a 
spectrum of fat accumulation and inflammation of the liver unrelated 
to alcohol consumption. NAFLD is primarily asymptomatic, but can 
be diagnosed by elevation of serum Alanine Amino Transferase (ALT) 
and Aspartate Transaminase (AST) with hepatic steatosis confirmed by 
ultrasonography and liver biopsy [5].
The combination of PCOS and NAFLD place patients at high risk 
for type 2 diabetes, visceral obesity and resistance to insulin as well as 
a manifold of other traditional cardiovascular risk factors especially 
intolerance, inflammation and procoagulation [6,7]. These in turn 
adversely affect pregnancy rates for women of reproductive age. 
Furthermore, pregnant women with a history of PCOS and NAFLD 
commonly develop gestational diabetes due to a predisposition to 
insulin resistance and have an increased risk for preeclampsia and 
preterm births [8-10].
Given the decreased fertility rate and adverse outcomes of pregnancy 
in women with NAFLD and PCOS, it is necessary to optimally manage 
these complex metabolic and reproductive disorders. There are several 
approaches to the treatment of subfertility found in women with 
PCOS. Lifestyle interventions are generally applied first, followed by 
oral treatments, and ending with more intensive strategies such as 
laparoscopic ovarian drilling and assisted reproductive techniques 
[1,11]. These methods have a limited effect, are costly or invasive. 
Moreover, some women with coexisting PCOS and metabolic syndrome 
may be unsuitable candidates for pharmaceutical medications due to 
impaired liver function. In this report we present a complex case of 
NAFLD, PCOS and infertility treated by Chinese herbal medicine.
Case in Detail
A 30 year-old woman visited our clinic for Chinese medicine 
treatment of oligomenorrhea with her cycles ranging between 40-60 
days and an absence of menses for the last 4 months. Despite being 
married for four years, she had failed to fall pregnant with no history 
of use of the contraceptive pill or other forms of contraception. Her 
husband was of the same age and had no remarkable health problems. 
The patient reported a strong appetite leading to weight gain of more 
than 5 kg in the last two years and a Body Mass Index (BMI) of 29 
kg/m². Physical examination revealed moderate hirsutism. Laboratory 
evaluations indicated an elevated Aspartate Transaminase (AST) level 
of 46 U/L, Alanine Transaminase (ALT) level of 106 U/L and gamma-
Glutamyl Transferase (GGT) level of 64 U/L (normal ranges of AST, 
ALT and GGT all <30); fasting serum cholesterol level of 8.0 mmol/L 
(normal range 3.5-5.4) and triglycerides level of 2.9 mmol/L (normal 
range 0.1-2.0). While there was a normal fasting plasma glucose level 
at 5.3 mmol/L (normal range 3.4-7.7) impaired glucose tolerance was 
revealed. Abdominal ultrasound showed an increased echodensity of the 
liver. This was consistent with moderate fatty infiltration, characteristic 
of simple steatosis in NAFLD. Pelvic ultrasound also revealed that both 
left and right ovaries contained multiple small follicles (each side 10 to 
15 follicles measuring up to 6 mm).
After an initial treatment with Chinese herbal medicine to induce 
menstruation, the patient gained her menses and subsequently 
underwent hormone testing on day 21 of her menstrual cycle. This 
identified Luteinising Hormone (LH) levels of 42 IU/L (normal range 
2-15), Follicle-Stimulating Hormone (FSH) levels of 15 IU/L (normal 
range 2-12), estrogen levels of 3520 pmol/L (normal range 370-770) 
and progesterone levels of 3 nmol/L (normal range 10.6-89.1). The 
androgens were abnormally high with a testosterone level of 3.8 nmol/L 
(normal range <2.6) and free androgen index of 9.7% (normal range 
<7.2) while De-hydro-epi-andro-sterone sulphate (DHEAS) had a level 
of 4.9 μmol/l (normal range 0.9–12) and Sex Hormone-Binding Protein 
(SHBP) levels of 39 nmol/l (normal range 20–118) within normal 
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had previously complied with lifestyle modifications, however had 
unsatisfactory results due to the complexity and severity of her 
metabolic abnormalities. We achieved her pregnancy and a healthy live 
birth with two sets of Chinese herbal formulae containing herbs with 
anti-obesity, lipid lowering and hepatoprotective effects to benefit both 
liver and ovary function.
In the treatment of PCOS, the contraceptive pill is often 
administered to suppress androgens and regulate the menstrual cycle 
[13]. However, this treatment strategy was not suitable for this patient 
who wanted to get pregnant as the OCT inhibits ovulation and prevents 
sperm penetration. Additionally the contraceptive pill does not treat 
NAFLD and is associated with the side effect of weight gain which can 
further aggravate PCOS and NAFLD related symptoms. Management of 
PCOS with pharmaceutical medications of metformin and clomiphene 
citrate has been well documented [11,13]. Clomiphene is used to 
increase ovarian stimulation to induce ovulation. However, clomiphene 
has limited efficacy and is associated with various side effects as well 
as hyper-ovarian stimulation [14]. Metformin is an insulin sensitiser 
that may improve insulin resistance to ameliorate both PCOS and 
NAFLD. However, metformin is not recommended for patients with 
liver dysfunction (elevated serum AST and/or ALT) [15]. Additionally, 
the patient presented with an absence of menses for four months and 
metformin may have a limited effect on inducing menstruation. For 
these reasons a natural approach was adopted.
In regards to Chinese herbal medicine there is considerable 
knowledge concerning both efficacy and safety for gynaecological 
disorders, such as irregular menstruation, amenorrhea and PCOS with 
infertility [16,17]. An advantage of CHM treatment is that it utilizes 
individualized formulas tailored to a patient’s condition. In this case, the 
first formula was used to improve her ‘blood stasis syndrome’ which in 
TCM is a phenomena related to amenorrhea, to induce her menses. The 
second formula mainly addressed the ovarian dysfunction with some of 
the herbal ingredients, such as Radix Salvia miltiorrhizae, and Rhizoma 
Coptis chinensis, also having beneficial effects on metabolic syndrome 
[18]. As a result, the treatment achieved not only her conception but 
also prevention of gestational diabetes during the pregnancy in this 
woman with multiple metabolic and reproductive conditions. CHM as 
an effective treatment for PCOS with subfertility has been evidenced 
by previous clinical studies [17]. These studies included 344 subjects 
who were diagnosed with PCOS and subfertility without NAFLD and 
hyperlipidaemia. The result of our case report demonstrates that CHM 
may be effective for complex metabolic and reproductive disorders 
with infertility.
Conclusion
In summary, herbal medicinal formulas may work on multiple 
targets simultaneously to improve metabolic syndrome manifestations 
such as PCOS, especially when there is more than one metabolic 
condition involved. More specifically, this case report demonstrates 
how herbal medicine can be applied to encourage the regularity of the 
menstrual cycle, promote ovulation and improve lipid metabolism to 
ameliorate PCOS and NAFLD related symptoms whilst also facilitating 
conception. The successful treatment with CHM for this case highlights 
a potential of natural therapy to manage coexisting NAFLD, PCOS 
and subfertility cohesively. The reliability of CHM for the treatment of 
complex endocrinal and reproductive disease is therefore worthwhile 
and needs to be implemented though rigorously designed randomized 
and controlled clinical trials.
ranges. According to the Rotterdam criteria this patient was diagnosed 
with PCOS [2].
Treatment
The patient was prescribed Lipitor for her hyper-lipidemia 
and referred to see a gynecologist for infertility. However, she was 
worried about hepatic-related side effects of the medication due to 
her impaired liver function. The patient therefore sought out Chinese 
medicine treatment at our clinic to maintain a regular menstrual cycle, 
lose weight, reduce cholesterol, normalize her liver function and fall 
pregnant.
Chinese Herbal Medicines (CHM) have been used traditionally 
to treat both gynaecological and liver related disorders. A special 
feature of CHM is that it utilizes formulas containing several herbs 
to ameliorate a group of clinical and biochemical abnormalities. For 
this patient, a basic formula was prescribed including Radix Angelicae 
sinensis (dang gui) 6 g, Radix Rehmannia glutinosa (shu di huang)10 
g, Semen Cuscutae Chinensis (tu si zi)15 g, Radix Salvia miltiorrhizae 
(dan shen)15 g, Fructus Crataegus pinnatifida (shan zha)15 g, Fructus 
Gardenia florida (zhi zi) 6 g and Rhizoma Coptis chinensis (huang lian) 
6 g. This formula was prepared as an 800 mL raw herbal decoction 
which was to be consumed four times over two days (200 mL twice per 
day). The aims of this particular herbal treatment were to regulate the 
menstrual cycle, promote ovulation, control metabolic abnormalities, 
reduce hepatic fat and reduce body weight. The patient therefore 
received 10 weeks of treatment.
Follow Up and Result
During the 10 weeks of treatment, the patient’s menstrual cycle 
became regular with cycles shortening to 32-36 days. A blood test 
was also performed at this stage and revealed improvement of fasting 
serum lipids including cholesterol from 8.0 down to 5.8 mmol/L and 
triglycerides from 2.9 to 1.7 mmol/L, as well as reduced serum hepatic 
enzymes AST 29, ALT 51 and GGT 33 U/L. After these 10 weeks, the 
treatment then continued with a new focus on promoting fertility to 
achieve pregnancy. The second formula included Radix Rehmannia 
glutinosa (shu di huang)15 g, Semen Cuscutae chinensis (tu si zi)15 g, 
Semen Morus multicaulis (sang shen zi)15 g, Fructus Lycium barbarum 
(gou qi zi)10 g, Herba Epimedium grandiflorum (yin yang huo)10 
g, Radix Salvia miltiorrhizae (dan shen)10 g, and Rhizoma Coptis 
chinensis (huang lian) 6 g and was prepared the same way as described 
previously. A day 3 hormone test performed 6 months after the initial 
hormone test revealed a remarkable change in testosterone (from 3.8 
to 1.3 nmol/L) and free androgen index (from 9.7% to 4.8%) with 
female hormones all within normal reference ranges for the follicular 
stage. Pregnancy was also achieved after 8 months of treatment with 
Chinese herbal medicines. The herbal treatment was then ceased after 
confirmation of pregnancy. During her pregnancy she did not develop 
gestational diabetes and had a natural labour giving birth to a healthy 
baby boy.
Discussion
This report details a case where a woman of childbearing age had 
profound hyperlipidemia, fatty liver disease and PCOS contributing 
to anovulatory infertility. For her complex disorders, a monotherapy 
approach may not have been effective. On the other hand, a 
combination of medications to treat PCOS and NAFLD simultaneously 
can be contradictory. For example, impaired liver function in this 
case hinders the use of lipid-lowering agents such as statins due to 
controversy of these drugs leading to liver toxicity [12]. The patient 
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